Dimeric p53 Mutant Elicits Unique Tumor-Suppressive Activities through an Altered Metabolic Program.
Cancer Discov
; 13(5): 1230-1249, 2023 05 04.
Article
in En
| MEDLINE
| ID: mdl-37067911
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Li-Fraumeni Syndrome
Type of study:
Risk_factors_studies
Limits:
Animals
Language:
En
Journal:
Cancer Discov
Year:
2023
Document type:
Article
Country of publication: